Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Trinity Biotech (TRIB) over the last 17 years, with Q2 2025 value amounting to $4.6 million.

  • Trinity Biotech's Non-Current Deferred Tax Liability rose 2052.84% to $4.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.6 million, marking a year-over-year increase of 2052.84%. This contributed to the annual value of $4.6 million for FY2024, which is 9830.43% up from last year.
  • Trinity Biotech's Non-Current Deferred Tax Liability amounted to $4.6 million in Q2 2025, which was up 2052.84% from $4.6 million recorded in Q4 2024.
  • In the past 5 years, Trinity Biotech's Non-Current Deferred Tax Liability registered a high of $5.4 million during Q2 2022, and its lowest value of $1.6 million during Q2 2023.
  • In the last 5 years, Trinity Biotech's Non-Current Deferred Tax Liability had a median value of $4.6 million in 2024 and averaged $4.0 million.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first plummeted by 6994.77% in 2023, then surged by 13523.93% in 2024.
  • Quarter analysis of 5 years shows Trinity Biotech's Non-Current Deferred Tax Liability stood at $4.9 million in 2021, then rose by 4.12% to $5.1 million in 2022, then plummeted by 54.53% to $2.3 million in 2023, then skyrocketed by 98.3% to $4.6 million in 2024, then increased by 0.02% to $4.6 million in 2025.
  • Its last three reported values are $4.6 million in Q2 2025, $4.6 million for Q4 2024, and $2.0 million during Q3 2024.